Editorials The wider role of regulatory scientists BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j1991 (Published 27 April 2017) Cite this as: BMJ 2017;357:j1991 Article Related content Metrics Responses Peer review Related articles Letter Neoliberal policies threaten the FDA’s regulatory mission Published: 12 June 2017; BMJ 357 doi:10.1136/bmj.j2764 Research Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis Published: 18 September 2019; BMJ 366 doi:10.1136/bmj.l5221 Feature Covid-19: Sputnik vaccine rockets, thanks to Lancet boost Published: 06 May 2021; BMJ 373 doi:10.1136/bmj.n1108 Feature FDA oversight of clinical trials is “grossly inadequate,” say experts Published: 16 November 2022; BMJ 379 doi:10.1136/bmj.o2628 See more Introductory Address Prov Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1 Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond's Prov Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10 Mr. Warburton's Bill for the Regulation of the Medical Profession Prov Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13 An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive Letterpress Prov Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4 A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &c Prov Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a Cited by... FDA oversight of clinical trials is "grossly inadequate," say expertsFulltext PDF Covid-19: Sputnik vaccine rockets, thanks to Lancet boostFulltext PDF Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysisFulltext PDF Abstract Neoliberal policies threaten the FDAs regulatory missionFulltext PDF Abstract